Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dyspnea × Fentanyl × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 27 Neoplasms 20 Cancer Pain 10 Colonic Neoplasms 7 Breakthrough Pain 7 Agnosia 7 Breast Neoplasms 5 Rectal Neoplasms 4 Prostatic Neoplasms 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Chronic Pain 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Pain, Postoperative 3 Lymphoma, Follicular 3 Breakthrough Cancer Pain 3 Waldenstrom Macroglobulinemia 2 Uterine Cervical Neoplasms 2 Thrombocythemia, Essential 2 Sezary Syndrome 2 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Pleural Effusion, Malignant 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Myeloproliferative Disorders 2 Mycosis Fungoides 2

Interventions

Surveys and Questionnaires 5 Oxygen 2 Dexamethasone 2 Calcium Dobesilate 2 Acupuncture Therapy 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Tiotropium Bromide 1 Sugars 1 Standard of Care 1 Respiratory Therapy 1 Rehabilitation 1 Psychiatric Rehabilitation 1 Midazolam 1 Losartan 1 Lisinopril 1 Hypnosis 1 Hematologic Tests 1 Furosemide 1 Fentanyl 1 Exercise 1 Educational Status 1 Echocardiography 1 Early Intervention, Educational 1 Dexmedetomidine 1 Caregivers 1 Buspirone 1 Behavior Therapy 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01515566 2014-08-22

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed

26 enrolled 7 charts

Dyspnea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡